We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
CALL
Edwards Lifesciences
EW
$53.2B
| $1.67M | ﹤0.01% |
19,600
-31,500
| -62% | -$2.59M |
|
1902
PUT
Tenet Healthcare
THC
$21.5B
| $1.67M | ﹤0.01% |
8,400
+7,200
| +600% | +$1.46M |
|
1903
Nuveen Global High Income Fund
JGH
$352M
| $1.66M | ﹤0.01% |
+132,015
| New | +$1.69M |
|
1904
CALL
Exelixis
EXEL
$12.5B
| $1.65M | ﹤0.01% |
37,700
-9,800
| -21% | -$405K |
|
1905
Constellation Energy
CEG
$99.8B
| $1.65M | ﹤0.01% |
4,673
+3,780
| +423% | +$1.37M |
|
1906
CRA International
CRAI
$1.07B
| $1.64M | ﹤0.01% |
8,195
+1,006
| +14% | +$190K |
|
1907
Workiva
WK
$3.91B
| $1.64M | ﹤0.01% |
+19,044
| New | +$1.69M |
|
1908
Kontoor Brands
KTB
$4.66B
| $1.64M | ﹤0.01% |
+26,865
| New | +$1.99M |
|
1909
PUT
Arista Networks
ANET
$254B
| $1.64M | ﹤0.01% |
12,500
-3,500
| -22% | -$482K |
|
|
MH
1910
McGraw Hill
MH
$2.44B
| $1.64M | ﹤0.01% |
+99,240
| New | +$1.44M |
|
1911
PUT
Rubrik
RBRK
$21.3B
| $1.64M | ﹤0.01% |
21,400
-28,600
| -57% | -$2.19M |
|
|
APLS
1912
DELISTED
Apellis Pharmaceuticals
APLS
| $1.64M | ﹤0.01% |
+65,133
| New | +$1.53M |
|
1913
Newmont
NEM
$124B
| $1.64M | ﹤0.01% |
+16,379
| New | +$1.48M |
|
|
BNY
1914
Bank of New York Mellon
BNY
$111B
| $1.63M | ﹤0.01% |
+14,083
| New | +$1.56M |
|
1915
CALL
Warby Parker
WRBY
$3.13B
| $1.63M | ﹤0.01% |
+75,000
| New | +$1.63M |
|
1916
Cameco
CCJ
$43.4B
| $1.63M | ﹤0.01% |
17,813
-306,485
| -95% | -$27.6M |
|
1917
CALL
Southwest Airlines
LUV
$22B
| $1.63M | ﹤0.01% |
39,400
| – | – |
|
1918
FuelCell Energy
FCEL
$1.75B
| $1.63M | ﹤0.01% |
+222,618
| New | +$1.82M |
|
1919
CALL
Darling Ingredients
DAR
$10.5B
| $1.62M | ﹤0.01% |
45,000
-39,500
| -47% | -$1.34M |
|
1920
Regions Financial
RF
$27.2B
| $1.62M | ﹤0.01% |
59,723
-6,455
| -10% | -$165K |
|
1921
CALL
Symbotic
SYM
$5.47B
| $1.61M | ﹤0.01% |
27,000
| – | – |
|
1922
Talos Energy
TALO
$2.62B
| $1.59M | ﹤0.01% |
144,366
-282,534
| -66% | -$2.96M |
|
1923
iShares US Aerospace & Defense ETF
ITA
$15B
| $1.59M | ﹤0.01% |
+7,400
| New | +$1.55M |
|
1924
Bausch + Lomb
BLCO
$6.11B
| $1.59M | ﹤0.01% |
+93,015
| New | +$1.48M |
|
|
MOB
1925
Mobilicom Ltd
MOB
$73.8M
| $1.59M | ﹤0.01% |
+260,212
| New | +$1.9M |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.